Immuneering | DEFA14A: Others
Apr 23 16:21 ET
Immuneering | DEF 14A: Definitive information statements
Apr 23 16:17 ET
Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(5.81%),Bihua Chen(5.81%), etc.
Apr 15 18:15 ET
Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(3.1%)
Apr 10 13:02 ET
Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.7%)
Apr 5 12:24 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP
Apr 3 17:39 ET
Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Merrin Investors LLC(9.46%)
Mar 27 13:14 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Schall Thomas J.
Mar 25 16:05 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Feinberg Peter
Mar 25 09:18 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Brakewood Harold Eugene
Mar 25 09:13 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Morales Mallory
Mar 25 09:08 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Neufeld Leah R
Mar 21 09:16 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Hall Brett Matthew
Mar 21 09:11 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Bookman Michael
Mar 19 19:18 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director BERMAN ANN E
Mar 19 19:13 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Feinberg Peter
Mar 19 19:07 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Zeskind Benjamin J.
Mar 19 19:02 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP
Mar 18 18:01 ET
Immuneering | 8-K: Current report
Mar 14 07:08 ET
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Schall Thomas J.
Mar 12 17:04 ET
No Data
No Data